|
Katholi [51]
|
1998
|
American Journal of Kidney Diseases
|
Springfield, Illinois
|
Parallel Group RCT with 2x2 factorial design
|
2 days
|
39
|
Allopurinol
|
Placebo
|
|
Perez-Ruiz [56]
|
1999
|
Journal of Clinical Rheumatology
|
Pais Vasco, Spain
|
Parallel Group RCT
|
9-12 months
|
36
|
Benzbromarone
|
Allopurinol
|
|
Kamper [50]
|
2001
|
Clinical Transplantation
|
Herlev, Denmark
|
Cross-over RCT
|
2 weeks
|
26
|
Losartan
|
No treatment
|
|
Schmidt [53]
|
2001
|
Nephrology Dialysis Transplantation
|
Vienna, Austria
|
Cross-over RCT
|
3 weeks
|
13
|
Losartan
|
Enalapril
|
|
Doehner [35]
|
2002
|
Circulation
|
London, UK
|
Cross-over RCT
|
2 weeks
|
14
|
Allopurinol
|
Placebo
|
|
Chanard [54]
|
2003
|
Nephrology Dialysis Transplantation
|
Three centres in France
|
Parallel Group RCT
|
2 months
|
48
|
Amlodipine
|
Tertatolol
|
|
Siu [48]
|
2006
|
American Journal of Kidney Diseases
|
Hong Kong, China
|
Parallel Group RCT
|
12 months
|
54
|
Allopurinol
|
No treatment
|
|
Liu [36]
|
2007
|
China Pharmacy
|
Guangzhou and Luzhou, China
|
Parallel Group RCT
|
12 months
|
47
|
Allopurinol
|
No treatment
|
|
Sarris [34]
|
2007
|
Nephrology Dialysis Transplantation
|
Athens, Greece
|
Parallel Group RCT
|
12 months
|
36
|
Allopurinol
|
No treatment
|
|
Lei [40]
|
2009
|
Shaanxi Medical Journal
|
Xi’an, China
|
Parallel Group RCT
|
12 months
|
57
|
Allopurinol
|
No treatment
|
|
Malaguarnera [55]
|
2009
|
Expert Opinion Pharmacotherapy
|
Catania, Italy
|
Parallel Group RCT
|
2 months
|
38
|
Rasburicase
|
Placebo
|
|
Nouri-Majalan [52]
|
2009
|
Vascular Health and Risk Management
|
Yazd, Iran
|
Parallel Group RCT
|
5 days
|
60
|
Allopurinol and vitamin E
|
No treatment
|
|
Deng [37]
|
2010
|
Journal of Practical Medicine
|
Beijing, China
|
Parallel Group RCT
|
12 months
|
68
|
Allopurinol
|
No treatment
|
|
Goicoechea [44]
|
2010
|
Clinical Journal of American Soc of Neph
|
Madrid, Spain
|
Parallel Group RCT
|
24 months
|
113
|
Allopurinol
|
No treatment
|
|
Momeni [46]
|
2010
|
Iranian Journal of Kidney Diseases
|
Isfahan, Iran
|
Parallel Group RCT
|
4 months
|
44
|
Allopurinol
|
Placebo
|
|
Shen [38]
|
2010
|
China Foreign Medical Treatment
|
Chengdu, China
|
Parallel Group RCT
|
12 months
|
52
|
Allopurinol
|
No treatment
|
|
Kao [45]
|
2011
|
Journal of American Soc of Neph
|
Dundee, UK
|
Parallel Group RCT
|
9 months
|
67
|
Allopurinol
|
Placebo
|
|
Tan [39]
|
2011
|
Modern Hospital
|
Guangzhou, China
|
Parallel Group RCT
|
24 months
|
140
|
Allopurinol
|
No treatment
|
|
Shi [47]
|
2012
|
Kidney and Blood Pressure Research
|
Guangzhou, China
|
Parallel Group RCT
|
6 months
|
40
|
Allopurinol
|
No treatment
|
